InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
T+90 hit rate
17%
T+90 mean return
-7.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Bruehlman Ronald E, Autre. Director active across 2 companies, notably Iqvia Holdings INC.. Aggregated, 17 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €4k. History available since 3 August 2021. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations17 total
73,434 sharesClass A Common StockSEC:0001809519-26-000125:0
4,642 shares0Class A Common StockSEC:0001809519-26-000117:0
21,691 sharesClass A Common StockSEC:0001809519-25-000145:0
57,050 shares0Class A Common StockSEC:0001809519-25-000090:0
907 shares@ US$206.979.2% of flowCommon StockSEC:0001478242-25-000037:0
6,286 shares0Common StockSEC:0001478242-25-000008:0
10,653 shares0Class A Common StockSEC:0001809519-25-000002:0
1,128 shares0Class A Common StockSEC:0001809519-24-000202:0
1,033 shares@ US$218.2010.6% of flowCommon StockSEC:0001478242-24-000027:0
24,141 shares0Common StockSEC:0001478242-24-000016:0
2,588 shares@ US$216.2925.9% of flowCommon StockSEC:0001478242-23-000089:0
717 shares@ US$230.317.8% of flowCommon StockSEC:0001478242-23-000028:0
2,588 shares@ US$233.2130.2% of flowCommon StockSEC:0001478242-22-000090:0
4 shares@ US$262.820.0000% mcap0.3% of flowCommon StockSEC:0001478242-22-000043:0
Ideal exit: 20 Jun 2022 (T+270)
13 shares@ US$245.320.0000% mcap0.8% of flowCommon StockSEC:0001478242-22-000022:0
Ideal exit: 16 Apr 2022 (T+270)
705 shares@ US$255.570.0006% mcap49.3% of flowCommon StockSEC:0001478242-22-000020:0
2,391 shares0Common StockSEC:0001478242-21-000052:0
17 of 17 declarations
About Bruehlman Ronald E
Ronald E. Bruehlman is associated with IQVIA HOLDINGS INC. His role is specified as 'See Remarks', indicating potential involvement in various aspects of the company. Ronald brings his expertise in health and data, contributing to the company's strategy and innovation. His experience is valuable in guiding IQVIA in a constantly evolving environment.
